| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |